Academic Endocrine Unit, Nuffield Department of Clinical Medicine, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Churchill Hospital, Oxford, United Kingdom.
PLoS One. 2010 May 14;5(5):e10646. doi: 10.1371/journal.pone.0010646.
SEDLIN, a 140 amino acid subunit of the Transport Protein Particle (TRAPP) complex, is ubiquitously expressed and interacts with the transcription factors c-myc promoter-binding protein 1 (MBP1), pituitary homeobox 1 (PITX1) and steroidogenic factor 1 (SF1). SEDLIN mutations cause X-linked spondyloepiphyseal dysplasia tarda (SEDT).
METHODOLOGY/PRINCIPAL FINDINGS: We investigated the effects of 4 missense (Asp47Tyr, Ser73Leu, Phe83Ser and Val130Asp) and the most C-terminal nonsense (Gln131Stop) SEDT-associated mutations on interactions with MBP1, PITX1 and SF1 by expression in COS7 cells. Wild-type SEDLIN was present in the cytoplasm and nucleus and interacted with MBP1, PITX1 and SF1; the SEDLIN mutations did not alter these subcellular localizations or the interactions. However, SEDLIN was found to homodimerize, and the formation of dimers between wild-type and mutant SEDLIN would mask a loss in these interactions. A mammalian SEDLIN null cell-line is not available, and the interactions between SEDLIN and the transcription factors were therefore investigated in yeast, which does not endogenously express SEDLIN. This revealed that all the SEDT mutations, except Asp47Tyr, lead to a loss of interaction with MBP1, PITX1 and SF1. Three-dimensional modelling studies of SEDLIN revealed that Asp47 resides on the surface whereas all the other mutant residues lie within the hydrophobic core of the protein, and hence are likely to affect the correct folding of SEDLIN and thereby disrupt protein-protein interactions.
CONCLUSIONS/SIGNIFICANCE: Our studies demonstrate that SEDLIN is present in the nucleus, forms homodimers and that SEDT-associated mutations cause a loss of interaction with the transcription factors MBP1, PITX1 and SF1.
SEDLIN 是运输蛋白颗粒 (TRAPP) 复合物的 140 个氨基酸亚基,广泛表达,与转录因子 c-myc 启动子结合蛋白 1 (MBP1)、垂体同源盒 1 (PITX1) 和类固醇生成因子 1 (SF1) 相互作用。SEDLIN 突变导致 X 连锁迟发性脊椎骨骺发育不良 (SEDT)。
方法/主要发现:我们通过在 COS7 细胞中的表达,研究了 4 个错义突变 (Asp47Tyr、Ser73Leu、Phe83Ser 和 Val130Asp) 和最 C 末端无义突变 (Gln131Stop) 对与 MBP1、PITX1 和 SF1 相互作用的影响。野生型 SEDLIN 存在于细胞质和细胞核中,并与 MBP1、PITX1 和 SF1 相互作用;SEDLIN 突变并未改变这些亚细胞定位或相互作用。然而,SEDLIN 被发现能够形成同源二聚体,并且野生型和突变型 SEDLIN 之间二聚体的形成会掩盖这些相互作用的丧失。目前尚无哺乳动物 SEDLIN 缺失细胞系,因此在不内源性表达 SEDLIN 的酵母中研究了 SEDLIN 与转录因子之间的相互作用。这表明,除了 Asp47Tyr 之外,所有 SEDT 突变都会导致与 MBP1、PITX1 和 SF1 的相互作用丧失。SEDLIN 的三维建模研究表明,Asp47 位于表面,而所有其他突变残基都位于蛋白质的疏水核心内,因此可能会影响 SEDLIN 的正确折叠,从而破坏蛋白质-蛋白质相互作用。
结论/意义:我们的研究表明,SEDLIN 存在于细胞核中,形成同源二聚体,并且 SEDT 相关突变导致与转录因子 MBP1、PITX1 和 SF1 的相互作用丧失。